Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Neutropenia and TP53[original query] |
---|
Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. The pharmacogenomics journal 2010 Feb 10 (1): 54-61. Khrunin A V, Moisseev A, Gorbunova V, Limborska |
Nucleotide excision repair gene polymorphisms may predict acute toxicity in patients treated with chemoradiotherapy for bladder cancer. Pharmacogenomics 2010 Oct 11 (10): 1377-87. Sakano Shigeru, Hinoda Yuji, Sasaki Miwa, Wada Takashi, Matsumoto Hiroaki, Eguchi Satoshi, Shinohara Asano, Kawai Yoshihisa, Hara Tomohiko, Nagao Kazuhiro, Hara Takahiko, Naito Katsusuke, Matsuyama Hideya |
MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide. Breast cancer research and treatment 2011 Jun . Okishiro M, Kim SJ, Tsunashima R, Nakayama T, Shimazu K, Shimomura A, Maruyama N, Tamaki Y, Noguchi S |
MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients. Oncology research and treatment 2014 37 (4): 176-80. Wang Xu, Wang Yi-Zhuo, Ma Ke-Wei, Chen Xiao, Li W |
Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 May 26 (5): 1012-8. Fu S, Hou M M, Naing A, Janku F, Hess K, Zinner R, Subbiah V, Hong D, Wheler J, Piha-Paul S, Tsimberidou A, Karp D, Araujo D, Kee B, Hwu P, Wolff R, Kurzrock R, Meric-Bernstam |
Somatic mutations and clonal hematopoiesis in congenital neutropenia. Blood 2017 11 131 (4): 408-416. Xia Jun, Miller Christopher A, Baty Jack, Ramesh Amrita, Jotte Matthew R M, Fulton Robert S, Vogel Tiphanie P, Cooper Megan A, Walkovich Kelly J, Makaryan Vahagn, Bolyard Audrey A, Dinauer Mary C, Wilson David B, Vlachos Adrianna, Myers Kasiani C, Rothbaum Robert J, Bertuch Alison A, Dale David C, Shimamura Akiko, Boxer Laurence A, Link Daniel |
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases. Breast cancer research and treatment 2018 Jun . Van Swearingen Amanda E D, Siegel Marni B, Deal Allison M, Sambade Maria J, Hoyle Alan, Hayes D Neil, Jo Heejoon, Little Paul, Dees Elizabeth Claire, Muss Hyman, Jolly Trevor, Zagar Timothy M, Patel Nirali, Miller C Ryan, Parker Joel S, Smith J Keith, Fisher Julie, Shah Nikita, Nabell Lisle, Nanda Rita, Dillon Patrick, Abramson Vandana, Carey Lisa A, Anders Carey |
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer. Cancer research and treatment 2018 Jan . Yoo Changhoon, Han Boram, Kim Hyeong Su, Kim Kyu-Pyo, Kim Deokhoon, Jeong Jae Ho, Lee Jae-Lyun, Kim Tae Won, Kim Jung Han, Choi Dae Ro, Ha Hong Il, Seo Jinwon, Chang Heung-Moon, Ryoo Baek-Yeol, Zang Dae You |
Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan. Cancer science 2019 3 110 (5): 1686-1694. Munakata Wataru, Ando Kiyoshi, Hatake Kiyohiko, Fukuhara Noriko, Kinoshita Tomohiro, Fukuhara Suguru, Shirasugi Yukari, Yokoyama Masahiro, Ichikawa Satoshi, Ohmachi Ken, Gion Naokazu, Aoi Arata, Tobinai Kens |
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3K? inhibitor therapy. Blood 2020 12 137 (20): 2817-2826. Mato Anthony R, Ghosh Nilanjan, Schuster Stephen J, Lamanna Nicole, Pagel John M, Flinn Ian W, Barrientos Jacqueline C, Rai Kanti R, Reeves James A, Cheson Bruce D, Barr Paul M, Kambhampati Suman, Lansigan Frederick, Pu Jeffrey J, Skarbnik Alan P, Roeker Lindsey, Fonseca Gustavo A, Sitlinger Andrea, Hamadeh Issam S, Dorsey Colleen, LaRatta Nicole, Weissbrot Hanna, Luning Prak Eline T, Tsao Patricia, Paskalis Dana, Sportelli Peter, Miskin Hari P, Weiss Michael S, Svoboda Jakub, Brander Danielle |
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia. Blood advances 2021 5 5 (9): 2438-2446. Tomowiak Cécile, Poulain Stéphanie, Herbaux Charles, Perrot Aurore, Mahé Béatrice, Morel Pierre, Aurran Thérèse, Tournilhac Olivier, Leprêtre Stéphane, Assaad Souad, Villemagne Bruno, Casasnovas Olivier, Nollet Delphine, Roos-Weil Damien, Chevret Sylvie, Leblond Véroniq |
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 2 39 (14): 1575-1583. Cluzeau Thomas, Sebert Marie, Rahmé Ramy, Cuzzubbo Stefania, Lehmann-Che Jacqueline, Madelaine Isabelle, Peterlin Pierre, Bève Blandine, Attalah Habiba, Chermat Fatiha, Miekoutima Elsa, Rauzy Odile Beyne, Recher Christian, Stamatoullas Aspasia, Willems Lise, Raffoux Emmanuel, Berthon Céline, Quesnel Bruno, Loschi Michael, Carpentier Antoine F, Sallman David A, Komrokji Rami, Walter-Petrich Anouk, Chevret Sylvie, Ades Lionel, Fenaux Pier |
Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 3809-3815. Nairuz Tahsin, Bushra Yearul Umme, Kabir Year |
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 1 39 (14): 1584-1594. Sallman David A, DeZern Amy E, Garcia-Manero Guillermo, Steensma David P, Roboz Gail J, Sekeres Mikkael A, Cluzeau Thomas, Sweet Kendra L, McLemore Amy, McGraw Kathy L, Puskas John, Zhang Ling, Yao Jiqiang, Mo Qianxing, Nardelli Lisa, Al Ali Najla H, Padron Eric, Korbel Greg, Attar Eyal C, Kantarjian Hagop M, Lancet Jeffrey E, Fenaux Pierre, List Alan F, Komrokji Rami |
Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. Dose-response : a publication of International Hormesis Society 0 20 (2): 15593258221111666. Spasic Jelena, Cavic Milena, Stanic Nemanja, Zaric Bojan, Kovacevic Tomi, Radosavljevic Davorin, Nagorni-Obradovic Ljudmi |
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. Leukemia 2022 4 36 (6): 1654-1665. Wong Jonathan, Gruber Emily, Maher Belinda, Waltham Mark, Sabouri-Thompson Zahra, Jong Ian, Luong Quinton, Levy Sidney, Kumar Beena, Brasacchio Daniella, Jia Wendy, So Joan, Skinner Hugh, Lewis Alexander, Hogg Simon J, Vervoort Stephin, DiCorleto Carmen, Uhe Micheleine, Gamgee Jeanette, Opat Stephen, Gregory Gareth P, Polekhina Galina, Reynolds John, Hawkes Eliza A, Kailainathan Gajan, Gasiorowski Robin, Kats Lev M, Shortt Ja |
Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 . Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, Noel Laudi, Mary W Redman, Jhanelle E Gray, David R Gandara, Karen Kel |
Gene polymorphism and prediction of toxicity to platinum-based chemotherapy in patients with gynecologic cancer. Clinical and translational science 2023 11 . Xuan Huang, Junmin Li, Xiaoying Pang, Jialei Zhu, Jiaqian Pan, Yueyan Li, Jing Ta |
A Phase I Study of the CDK4/6 Inhibitor, Palbociclib in Combination with Cetuximab and Radiotherapy (IMRT) for Locally Advanced Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 . Nuttapong Ngamphaiboon, Poompis Pattaranutaporn, Somthawin Lukerak, Teerada Siripoon, Artit Jinawath, Lalida Arsa, Prapimporn Ch Shantavasinkul, Naphat Taonam, Narumol Trachu, Natini Jinawath, Arpakorn Kositwattanarerk, Thiparom Sananmuang, Chuleeporn Jiarpinitn |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: